FR36M - New drug, in particular for the treatment of postprandial or acute hyperlipemia. - Google Patents

New drug, in particular for the treatment of postprandial or acute hyperlipemia.

Info

Publication number
FR36M
FR36M FR832912A FR832912A FR36M FR 36 M FR36 M FR 36M FR 832912 A FR832912 A FR 832912A FR 832912 A FR832912 A FR 832912A FR 36 M FR36 M FR 36M
Authority
FR
France
Prior art keywords
postprandial
treatment
new drug
acute hyperlipemia
hyperlipemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR832912A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Application granted granted Critical
Publication of FR36M publication Critical patent/FR36M/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR832912A 1959-11-20 1960-07-13 New drug, in particular for the treatment of postprandial or acute hyperlipemia. Expired FR36M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR810809A FR1359605A (en) 1959-11-20 1959-11-20 2-methylated cyclopentanophenanthrenic derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
FR36M true FR36M (en) 1960-11-28

Family

ID=8721585

Family Applications (2)

Application Number Title Priority Date Filing Date
FR810809A Expired FR1359605A (en) 1959-11-20 1959-11-20 2-methylated cyclopentanophenanthrenic derivatives and process for their preparation
FR832912A Expired FR36M (en) 1959-11-20 1960-07-13 New drug, in particular for the treatment of postprandial or acute hyperlipemia.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR810809A Expired FR1359605A (en) 1959-11-20 1959-11-20 2-methylated cyclopentanophenanthrenic derivatives and process for their preparation

Country Status (5)

Country Link
BE (1) BE597232A (en)
CH (1) CH406201A (en)
ES (1) ES262354A1 (en)
FR (2) FR1359605A (en)
GB (1) GB913052A (en)

Also Published As

Publication number Publication date
FR1359605A (en) 1964-04-30
BE597232A (en) 1961-05-18
GB913052A (en) 1962-12-19
CH406201A (en) 1966-01-31
ES262354A1 (en) 1961-01-16

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR1593M (en) Compositions for the treatment of acne.
FR362M (en) New drug for the treatment of staphylococcal infections and salmonellosis.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR36M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR365M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR1288M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2656M (en) New drug, in particular for the treatment of chronic or postprandial hyperlipemia.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR1172M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR31M (en) New drug in particular for the treatment of arterial hypertension.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR22M (en) New drug in particular for the treatment of acute or chronic articular rheumatism.
FR153M (en) New isopropylated drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2148M (en) Topical composition for the treatment of warts.
FR1731M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.